Pharmacogenomics in the clinic

被引：551

作者：

Relling, Mary V. ^{[1
]}

Evans, William E. ^{[1
]}

机构：

[1] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA

来源：

NATURE | 2015年 / 526卷 / 7573期

关键词：

IMPLEMENTATION CONSORTIUM GUIDELINES; PERSONALIZED MEDICINE; ECONOMIC-EVALUATION; DECISION-SUPPORT; RESEARCH NETWORK; GENETIC-CONTROL; DRUG-REACTIONS; GENOTYPE; CYP2D6; GENOMICS;

D O I：

10.1038/nature15817

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

After decades of discovery, inherited variations have been identified in approximately 20 genes that affect about 80 medications and are actionable in the clinic. And some somatically acquired genetic variants direct the choice of 'targeted' anticancer drugs for individual patients. Current efforts that focus on the processes required to appropriately act on pharmacogenomic variability in the clinic are moving away from discovery and towards implementation of an evidenced-based strategy for improving the use of medications, thereby providing a cornerstone for precision medicine.

引用

页码：343 / 350

页数：8

共 111 条

[21] Role of phenotypic and genetic testing in managing clopidogrel therapy
Chan, Noel C.
Eikelboom, John W.
Ginsberg, Jeffrey S.
Lauw, Mandy N.
Vanassche, Thomas
Weitz, Jeffrey I.
Hirsh, Jack
[J]. BLOOD, 2014, 124 (05) : 689 - 699
[22] Effects of a HLA-B*15:02 screening policy on antiepileptic drug use and severe skin reactions
Chen, Zhibin
Liew, Danny
Kwan, Patrick
[J]. NEUROLOGY, 2014, 83 (22) : 2077 - 2084
[23] Karyotypic abnormalities create discordance of germline genotype and cancer cell phenotypes
Cheng, Q
Yang, WJ
Raimondi, SC
Pui, CH
Relling, MV
Evans, WE
[J]. NATURE GENETICS, 2005, 37 (08) : 878 - 882
[24] Bridging genomics research between developed and developing countries: the Genomic Medicine Alliance
Cooper, David N.
Brand, Angela
Dolzan, Vita
Fortina, Paolo
Innocenti, Federico
Lee, Ming Ta Michael
Macek, Milan, Jr.
Al-Mulla, Fahd
Prainsack, Barbara
Squassina, Alessio
Vayena, Effy
Vozikis, Athanassios
Williams, Marc S.
Patrinos, George P.
[J]. PERSONALIZED MEDICINE, 2014, 11 (07) : 615 - 623
[25] eMERGEing progress in genomics-the first seven years
Crawford, Dana C.
Crosslin, David R.
Tromp, Gerard
Kullo, Iftikhar J.
Kuivaniemi, Helena
Hayes, M. Geoffrey
Denny, Joshua C.
Bush, William S.
Haines, Jonathan L.
Roden, Dan M.
McCarty, Catherine A.
Jarvik, Gail P.
Ritchie, Marylyn D.
[J]. FRONTIERS IN GENETICS, 2014, 5
[26] Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update
Crews, K. R.
Gaedigk, A.
Dunnenberger, H. M.
Leeder, J. S.
Klein, T. E.
Caudle, K. E.
Haidar, C. E.
Shen, D. D.
Callaghan, J. T.
Sadhasivam, S.
Prows, C. A.
Kharasch, E. D.
Skaar, T. C.
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (04) : 376 - 382
[27] DruGeVar: An Online Resource Triangulating Drugs with Genes and Genomic Biomarkers for Clinical Pharmacogenomics
Dalabira, Eleni
Viennas, Emmanouil
Daki, Elisavet
Komianou, Angeliki
Bartsakoulia, Marina
Poulas, Konstantinos
Katsila, Theodora
Tzimas, Giannis
Patrinos, George P.
[J]. PUBLIC HEALTH GENOMICS, 2014, 17 (5-6) : 265 - 271
[28] Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers
Dunnenberger, Henry M.
Crews, Kristine R.
Hoffman, James M.
Caudle, Kelly E.
Broeckel, Ulrich
Howard, Scott C.
Hunkler, Robert J.
Klein, Teri E.
Evans, William E.
Relling, Mary V.
[J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55, 2015, 55 : 89 - +
[29] Pharmacogenomic information in drug labels: European Medicines Agency perspective
Ehmann, F.
Caneva, L.
Prasad, K.
Paulmichl, M.
Maliepaard, M.
Llerena, A.
Ingelman-Sundberg, M.
Papaluca-Amati, M.
[J]. PHARMACOGENOMICS JOURNAL, 2015, 15 (03) : 201 - 210
[30] GENETIC CONTROL OF ISONIAZID METABOLISM IN MAN
EVANS, DAP
MANLEY, KA
MCKUSICK, VA
[J]. BRITISH MEDICAL JOURNAL, 1960, 2 (AUG13) : 485 - 491

← 1 2 3 4 5 6 7 8 9 10 →